Primary hypercholesterolaemia impairs glucose homeostasis and insulin secretion in low-density lipoprotein receptor knockout mice independently of high-fat diet and obesity

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 2, 2010, Pages 183-190

  Bonfleur, Maria Lúcia ^a   Vanzela, Emerielle Cristine ^a   Ribeiro, Rosane Aparecida ^a   de Gabriel Dorighello, Gabriel ^a   de França Carvalho, Carolina Prado ^b   Collares Buzato, Carla Beatriz ^b   Carneiro, Everardo Magalhães ^a   Boschero, Antonio Carlos ^a   de Oliveira, Helena Coutinho Franco ^a  

^a Fisiologia e Biofísica   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cholesterol; Glucose homeostasis; Hypercholesterolaemia; Insulin secretion; LDL receptor; Pancreatic islet

Indexed keywords

CHOLESTEROL; DNA; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HYPERCHOLESTEROLEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET CELL; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; BETA-CYCLODEXTRINS; CHOLESTEROL; DIETARY FATS; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HYPERCHOLESTEROLEMIA; INSULIN; ISLETS OF LANGERHANS; LEUCINE; LIPIDS; MALE; MICE; MICE, KNOCKOUT; OBESITY; OXIDATION-REDUCTION; RECEPTORS, LDL;

MUS;

EID: 73749088455     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.10.012     Document Type: Article

References (48)

1. Goldstein J.L., and Brown M.S. Atherosclerosis and its complications: contributions from the Association of American Physicians, 1886-1986. Trans. Assoc. Am. Physicians 99 (1986) ccxxxi-ccxlvii
2. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., and Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92 (1993) 883-893
3. Hobbs H.H., Brown M.S., and Goldstein J.L. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutat. 1 (1992) 445-466
4. Scanu A.M., Khalil A., Neven L., Tidore M., Dawson G., Pfaffinger D., Jackson E., Carey K.D., McGill H.C., and Fless G.M. Genetically determined hypercholesterolemia in a rhesus monkey family due to a deficiency of the LDL receptor. J. Lipid. Res. 29 (1988) 1671-1681
5. Fan J., and Watanabe T. Cholesterol-fed and transgenic rabbit models for the study of atherosclerosis. J. Atheroscler. Thromb. 7 (2000) 26-32
6. Ishibashi S., Goldstein J.L., Brown M.S., Herz J., and Burns D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93 (1994) 1885-1893
7. Heath K.E., Gahan M., Whittall R.A., and Humphries S.E. Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolaemia: update, new features and mutation analysis. Atherosclerosis 154 (2001) 243-246
8. Yuan G., Wang J., and Hegele R.A. Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease. CMAJ 174 (2006) 1124-1129
9. Uusitupa M.I., Niskanen L.K., Siitonen O., Voutilainen E., and Pyorala K. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation 82 (1990) 27-36
10. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes. Care. 16 (1993) 434-444
11. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease. The Framingham study. Jama 241 (1979) 2035-2038
12. Wilson P.W., McGee D.L., and Kannel W.B. Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: the Framingham Study. Am. J. Epidemiol. 114 (1981) 697-704
13. Lewis G.F., Carpentier A., Adeli K., and Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23 (2002) 201-229
14. Cerf M.E. High fat diet modulation of glucose sensing in the beta-cell. Med. Sci. Monit. 13 (2007) RA12-RA17
15. Eto K., Yamashita T., Matsui J., Terauchi Y., Noda M., and Kadowaki T. Genetic manipulations of fatty acid metabolism in beta-cells are associated with dysregulated insulin secretion. Diabetes 51 Suppl. 3 (2002) S414-S420
16. Poitout V., and Robertson R.P. Minireview: secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 143 (2002) 339-342
17. Merat S., Casanada F., Sutphin M., Palinski W., and Reaven P.D. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1223-1230
18. Ginsberg H.N., and Tuck C. Diabetes and dyslipidemia. Curr. Diab. Rep. 1 (2001) 93-95
19. Zhou Y.P., and Grill V.E. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93 (1994) 870-876
20. Grupping A.Y., Cnop M., Van Schravendijk C.F., Hannaert J.C., Van Berkel T.J., and Pipeleers D.G. Low density lipoprotein binding and uptake by human and rat islet beta cells. Endocrinology 138 (1997) 4064-4068
21. Cnop M., Hannaert J.C., Grupping A.Y., and Pipeleers D.G. Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification. Endocrinology 143 (2002) 3449-3453
22. Roehrich M.E., Mooser V., Lenain V., Herz J., Nimpf J., Azhar S., Bideau M., Capponi A., Nicod P., Haefliger J.A., and Waeber G. Insulin-secreting beta-cell dysfunction induced by human lipoproteins. J. Biol. Chem. 278 (2003) 18368-18375
23. Cnop M., Grupping A., Hoorens A., Bouwens L., Pipeleers-Marichal M., and Pipeleers D. Endocytosis of low-density lipoprotein by human pancreatic beta cells and uptake in lipid-storing vesicles, which increase with age. Am. J. Pathol. 156 (2000) 237-244
24. Girotti A.W. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J. Lipid Res. 39 (1998) 1529-1542
25. Inuwa I.M., and El Mardi A.S. Correlation between volume fraction and volume-weighted mean volume, and between total number and total mass of islets in post-weaning and young Wistar rats. J. Anat. 206 (2005) 185-192
26. Carvalho C.P., Martins J.C., da Cunha D.A., Boschero A.C., and Collares-Buzato C.B. Histomorphology and ultrastructure of pancreatic islet tissue during in vivo maturation of rat pancreas. Ann. Anat. 188 (2006) 221-234
27. Sone H., and Kagawa Y. Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48 (2005) 58-67
28. Boschero A.C., and Delattre E. The mechanism of gentamicin-inhibited insulin release by isolated islets. Arch. Int. Pharmacodyn. Ther. 273 (1985) 167-176
29. Hao M., Head W.S., Gunawardana S.C., Hasty A.H., and Piston D.W. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes 56 (2007) 2328-2338
30. Li A.C., Brown K.K., Silvestre M.J., Willson T.M., Palinski W., and Glass C.K. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 106 (2000) 523-531
31. Schreyer S.A., Lystig T.C., Vick C.M., and LeBoeuf R.C. Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity. Atherosclerosis 171 (2003) 49-55
32. Chisolm III G.M., and Morel D.W. Lipoprotein oxidation and cytotoxicity: effect of probucol on streptozotocin-treated rats. Am. J. Cardiol. 62 (1988) 20B-26B
33. 2 concentrations in isolated neonatal rat islets. Biochim. Biophys. Acta 1690 (2004) 159-168
34. Okajima F., Kurihara M., Ono C., Nakajima Y., Tanimura K., Sugihara H., Tatsuguchi A., Nakagawa K., Miyazawa T., and Oikawa S. Oxidized but not acetylated low-density lipoprotein reduces preproinsulin mRNA expression and secretion of insulin from HIT-T15 cells. Biochim. Biophys. Acta 1687 (2005) 173-180
35. Palinski W., Tangirala R.K., Miller E., Young S.G., and Witztum J.L. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1569-1576
36. Rorsman P. [Electrophysiological studies of insulin secretion, physiology and pathophysiology]. Nord. Med. 112 (1997) 164-168
37. Malaisse W.J., Hutton J.C., Carpinelli A.R., Herchuelz A., and Sener A. The stimulus-secretion coupling of amino acid-induced insulin release: metabolism and cationic effects of leucine. Diabetes 29 (1980) 431-437
38. Lenzen S., Schmidt W., Rustenbeck I., and Panten U. 2-ketoglutarate generation in pancreatic B-cell mitochondria regulates insulin secretory action of amino acids and 2-keto acids. Biosci. Rep. 6 (1986) 163-169
39. Gao Z.Y., Li G., Najafi H., Wolf B.A., and Matschinsky F.M. Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes 48 (1999) 1535-1542
40. Malaisse W.J., Sener A., Malaisse-Lagae F., Welsh M., Matthews D.E., Bier D.M., and Hellerstrom C. The stimulus-secretion coupling of amino acid-induced insulin release. Metabolic response of pancreatic islets of l-glutamine and l-leucine. J. Biol. Chem. 257 (1982) 8731-8737
41. Lenzen S., Formanek H., and Panten U. Signal function of metabolism of neutral amino acids and 2-keto acids for initiation of insulin secretion. J. Biol. Chem. 257 (1982) 6631-6633
42. Oliveira H.C., Cosso R.G., Alberici L.C., Maciel E.N., Salerno A.G., Dorighello G.G., Velho J.A., de Faria E.C., and Vercesi A.E. Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria. Faseb. J. 19 (2005) 278-280
43. Paim B.A., Velho J.A., Castilho R.F., Oliveira H.C., and Vercesi A.E. Oxidative stress in hypercholesterolemic LDL (low-density lipoprotein) receptor knockout mice is associated with low content of mitochondrial NADP-linked substrates and is partially reversed by citrate replacement. Free Radic. Biol. Med. 44 (2008) 444-451
44. Xia F., Gao X., Kwan E., Lam P.P., Chan L., Sy K., Sheu L., Wheeler M.B., Gaisano H.Y., and Tsushima R.G. Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J. Biol. Chem. 279 (2004) 24685-24691
45. Vikman J., Jimenez-Feltstrom J., Nyman P., Thelin J., and Eliasson L. Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. FASEB J. 23 (2009) 58-67
46. Xia F., Xie L., Mihic A., Gao X., Chen Y., Gaisano H.Y., and Tsushima R.G. Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells. Endocrinology 149 (2008) 5136-5145
47. Velho J.A., Okanobo H., Degasperi G.R., Matsumoto M.Y., Alberici L.C., Cosso R.G., Oliveira H.C., and Vercesi A.E. Statins induce calcium-dependent mitochondrial permeability transition. Toxicology 219 (2006) 124-132
48. Elsayed R.K., and Evans J.D. Emerging lipid-lowering drugs: squalene synthase inhibitors. Expert. Opin. Emerg. Drugs. 13 (2008) 309-322